Effect of warfarin sodium therapy on excretion of 4‐carboxy‐L‐glutamic acid in scleroderma, dermatomyositis, and myositis ossificans progressiva

Arthritis & Rheumatism

Volumn 29, Issue 3, 1986, Pages 344-351

  Moore, Sterling E ^a   Jump, Adrien A ^a   Smiley, J Donald ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 CARBOXYGLUTAMIC ACID; CALCIUM; PHOSPHORUS; WARFARIN;

ADVERSE DRUG REACTION; CALCIFICATION; CLINICAL ARTICLE; DERMATOMYOSITIS; DRUG ANALYSIS; DRUG DETERMINATION; DRUG MECHANISM; DRUG MONITORING; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; HUMAN; MUSCLE; MUSCULOSKELETAL SYSTEM; OSSIFYING MYOSITIS; PRIORITY JOURNAL; SCLERODERMA; THERAPY; URINARY TRACT;

ADULT; BONE AND BONES; CALCIUM; CARBON RADIOISOTOPES; CASE REPORT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC AMP; DERMATOMYOSITIS; FEMALE; FOLLOW-UP STUDIES; GLUTAMATES; HEMORRHAGE; HUMAN; MALE; MIDDLE AGE; MYOSITIS OSSIFICANS; PHOSPHORUS; SCLERODERMA, SYSTEMIC; SUPPORT, NON-U.S. GOV'T; WARFARIN;

EID: 0022624830     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780290306     Document Type: Article

References (40)

1. Cutaneous calcinosis in localized discoid lupus erythematosus
2. Calcinosis cutis: its relationship to scleroderma
3. Dermatomyositis, scleroderma and polyarteritis nodosa
4. Myositis ossificans progressiva: a review of current problems
5. The mode of action of vitamin K: isolation of a peptide containing the vitamin K‐dependent portion of prothrombin
6. The mode of action of vitamin K: identification of γ‐carboxy‐glutamic acid as a component of prothrombin
7. Vitamin K dependent modifications of glutamic acid residues in prothrombin
8. The presence of γ‐carboxyglutamic acid in the proteins associated with ectopic calcification
9. Scleroderma and microangiopathic hemolytic anemia
10. Fibrinogen turnover in progressive systemic sclerosis
11. Progressive systemic sclerosis and malignant hypertension: an immunohistochemical study of renal lesions
12. Treatment of Raynaud's phenomenon by fibrinolytic enhancement
13. Fibrinogen catabolism in systemic lupus erythematosus
14. Coagulation abnormalities in rheumatoid disease
15. Treatment of calcinosis universalis secondary to dermatomyositis or scleroderma with low dose warfarin (abstract)
16. Direct identification of the calcium‐binding amino acid, γ‐carboxyglutamate, in mineralized tissue
17. γ‐carboxyglutamate analysis by selective anion exchange elution and fluorescent detection
18. A HPLC method for the simultaneous determination of Gla and Glu in proteins, bone and urine
19. Amino acid analysis with o‐phthalaldehyde detection: effects of reaction temperature and thiol on fluorescence yields
20. O‐phthalaldehyde: fluorogenic detection of primary amines in the picomole range: comparison with fluorescamine and ninhydrin
21. Analysis of γ‐carboxyglutamic acid via amino acid analysis
22. Quantitative determination of γ‐carboxyglutamic acid in proteins
23. γ‐carboxyglutamic acid in human urine
24. Primary structure of the vitamin K‐dependent part of prothrombin
25. Cross‐linking of fibronectin to collagen by blood coagulation factor XIIIa
26. γ‐carboxyglutamate excretion and warfarin therapy
27. Isolation and sequence of the vitamin K‐dependent protein from human bone
28. Presence of osteocalcin and related higher molecular weight 4‐carboxyglutamic acid‐containing proteins in developing bone
29. Matrix Gla protein, a new γ‐carboxyglutamic acid‐containing protein which is associated with the organic matrix of bone
30. Anticoagulant therapy with cardiac valve prosthesis during pregnancy
31. Congenital malformations associated with the administration of oral anticoagulants during pregnancy
32. Maternal and fetal sequelae of anticoagulation during pregnancy
33. Excessive mineralization with growth plate closure in rats on chronic warfarin treatment
34. The presence of protein‐bound γ‐carboxyglutamic acid in calcium‐containing renal calculi
35. Metabolism and transport of γ‐carboxyglutamic acid
36. γ‐carboxyglutamate excretion: a marker in patients with ectopic calcification disorders (abstract)
37. Gamma‐carboxyglutamate excretion and calcinosis in juvenile dermatomyositis
38. Effects of warfarin on bone: studies on the vitamin K‐dependent protein of rat bone